MHH Logo

Melike Küçükerden



Master of Science Neuroscience

PhD Student

PhD program Systems Neuroscience (in cooperation with TiHo Hannover)

Building J03, Level 04, Room 1300
Phone.: +49(0)511/532-8303
FAX: +49(0)511/532-8801


E-mail: kuecuekerden.melike(at)

Research interests

Altered brain development and behavioral consequences in mice with region- and cell type-specific deletions of the glycosyltransferase ST8SIA2.




Erdağ E, Şahin C, Küçükali Cİ, Bireller S, Küçükerden M, et al. Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG. Neurol Sci. 2017 Feb 21.


Esen F, Orhun G, Ozcan PE, Senturk E, Kucukerden M, et al. Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis. Intensive Care Med Exp. 2017 Dec;5(1):1.


Küçükerden M, Tüzün E, Tzartos S, Strait R, Finkelman F, Christadoss P. MuSK induced experimental autoimmune myasthenia gravis does not require  IgG1 antibody to MuSK. J Neuroimmunol. 2016 Jun 15;295-296:84-92.


Ulusoy C, Zibandeh N, Yıldırım S, Trakas N, Zisimopoulou P, Küçükerden M, et al. Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in Musk-immunized mice. Journal of Neuroinflammation. 2015 Dec 9;12:231.


Sehitoğlu E, Cavuş F, Ulusoy C, Küçükerden M, et al. Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple  sclerosis: a preliminary study. Inflamm Res. 2014 Oct;63(10):799-801.


Türkoğlu R, Gencer M, Ekmekçi D, Ulusoy C, Erdağ E, Sehitoğlu E, Cavuş F, Haytural H, Küçükerden M, et al. Switch-associated protein 70 antibodies in multiple sclerosis: possible association with disease progression. Med Princ Pract. 2014;23(3):239-45


Vural B, Sehitoğlu E, Cavuş F, Yalçınkaya N, Haytural H, Küçükerden M, et al. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease. J Neuroimmunology 2013 Oct 15;263(1-2):139-44.